Cigna Ventures is the strategic venture capital arm of Cigna Corporation, investing in early and growth-stage healthcare services and technology companies. Its focus is on innovative solutions that enhance access, support, and value for customers, specifically across insights and analytics, digital health and experience, and care delivery and enablement.
75% of their portfolio is in Healthcare. Average disclosed round size is $78.5M (across 12 rounds with reported amounts).
Portfolio
12
Fund Size
$700M
Top Stage
Growth
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 9amHealth | Series A | $9.5M | Feb 2024 |
 Octave | Series C | $52M | Jun 2023 |
 Valera Health | Growth | $44.5M | Oct 2022 |
 Alma | Series D | $130M | Aug 2022 |
 Cricket Health | Series B | $83.5M | Aug 2021 |
| CCleerly Coronary | Series B | $43M | Jun 2021 |
 Datavant | Series B | $40M | Oct 2020 |
 Arcadia | Growth | $29.5M | Jan 2020 |
 Omada Health | Series C | $73M | Jun 2019 |
| AAutonomize AI | Series A | $28M | — |
 Monogram Health | Growth | $375M | — |
 NOCD | Unknown | $34M | — |
Top Co-Investors
Valtruis2 shared
Kaiser Permanente Ventures2 shared
Heritage Group1 shared
Windham Venture Partners1 shared
AXA Venture Partners1 shared
Aquiline1 shared
Thoma Bravo1 shared
Optum Ventures1 shared
Tusk Ventures1 shared
Vensana Capital1 shared
New Leaf Venture Partners1 shared
DigiTx Partners1 shared
Tau Ventures1 shared
Transformation Capital1 shared
Flex1 shared
Greycroft1 shared
Felicis Ventures1 shared
Novo Holdings1 shared
Avidity Partners1 shared
Health Velocity Capital1 shared
Last updated: 16 April 2026